Alkem Laboratories Ltd.

4757.80 +42.15 ▲0.9%

16 April 2024, 02:07:57 PM
Volume: 85,479

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alkemlabs.com
Market Cap 56,240.39 Cr.
Enterprise Value(EV) 54,242.50 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 131.58 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 35.75 Trailing Twelve Months Ending 2023-12
Industry PE 40.96 Trailing Twelve Months Ending 2023-12
Book Value / Share 873.73 Trailing Twelve Months Ending 2023-12
Price to Book Value 5.38 Calculated using Price: 4,703.75
Dividend Yield 1.06 Period Ending 2023-03
No. of Shares Subscribed 11.96 Cr. 119,565,000 Shares
FaceValue 2
About Alkem Laboratories Ltd.
The company is one of India's foremost global pharmaceutical company. The company is engaged in the development, manufacture and marketing of pharmaceuticals with operational footprints across different countries. In India, it has a formidable presence in several therapy segments and consistently features amongst the top ten pharmaceutical companies. Steered by its industry experience of over four decades, it offers high-quality branded generics, generic drugs, active pharmaceutical ingredients and nutraceuticals.

Alkem Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Alkem Laboratories Ltd. Performance

1 Day
+0.89%
1 Week
-2.67%
1 Month
-5.70%
3 Month
-5.55%
6 Month
+31.71%
1 Year
+42.23%
2 Year
+39.11%
5 Year
+171.22%
10 Year

Alkem Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.03 22.48 22.18 13.69 15.02 19.82 23.91 20.99 11.39
Return on Capital Employed (%) 13.27 23.1 21.31 17.86 16.49 18.71 22.56 18.69 13.09
Return on Assets (%) 8.16 14.59 16.61 9.91 10.66 13.92 16.66 14.5 7.99

Alkem Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2,999 3,692 4,468 4,864 5,439 6,161 7,377 8,638 9,045 9,842
Non Curr. Liab. 201 -306 -401 -359 -289 -541 -751 -893 -688 -643
Curr. Liab. 2,006 1,538 1,690 2,383 2,218 3,245 3,604 4,805 3,707 3,912
Minority Int. 86 95 115 122 133 148 181 209 390 382
Equity & Liab. 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,454 13,494
Non Curr. Assets 2,953 2,250 2,955 2,997 3,284 3,507 3,483 4,325 3,724 3,832
Curr. Assets 2,338 2,769 2,915 4,013 4,204 5,488 6,923 8,434 8,606 9,662
Misc. Exp. not W/O
Total Assets 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,454 13,494

Alkem Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 3,743 4,925 5,688 6,392 7,357 8,344 8,865 10,634 11,599 12,634
Other Income 181 240 112 115 88 104 233 163 216 291
Total Income 3,924 5,165 5,800 6,507 7,445 8,449 9,098 10,797 11,815 12,926
Total Expenditure -3,322 -4,072 -4,689 -5,383 -6,242 -6,871 -6,923 -8,581 -9,990 -10,438
PBIDT 603 1,093 1,111 1,124 1,202 1,578 2,176 2,216 1,826 2,488
Interest -81 -71 -45 -55 -55 -65 -59 -52 -107 -115
Depreciation -71 -93 -101 -143 -193 -253 -275 -304 -310 -294
Taxation -59 -176 -60 -288 -181 -110 -224 -164 -298 -293
Exceptional Items -15 -103 -212
PAT 392 752 905 638 774 1,149 1,618 1,680 1,007 1,575
Minority Interest -11 -13 -7 -13 -22 -33 -35 -23 -1
Share Associate
Other Related Items
Consolidated Net Profit 392 742 892 631 761 1,127 1,585 1,646 984 1,573
Adjusted EPS 33 62 75 53 64 94 133 138 82 132

Alkem Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 290 325 726 471 266 780 585 1,265 1,111 1,683
Cash Fr. Inv. 350 -237 202 -286 -357 -316 -741 -999 -1,435 113
Cash Fr. Finan. -600 -52 -927 -138 85 -379 79 -272 380 -1,761
Net Change 41 37 1 47 -7 84 -77 -5 55 35
Cash & Cash Eqvt 101 140 127 167 167 249 176 174 232 274

Alkem Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 57.13 57.13 57.14 57.16 57.16 57.16 57.16 56.74 56.74
Public 42.87 42.87 42.86 42.84 42.84 42.84 42.84 43.26 43.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Alkem Laboratories Ltd. Announcements

Mon, 08 Apr 2024
Shareholders meeting
Alkem Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Mon, 08 Apr 2024
Disclosure under SEBI Takeover Regulations
Basudeo N Singhᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ᅡᅠ
Mon, 08 Apr 2024
Updates
Alkem Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Alkem Laboratories Ltd. Technical Scans

Mon, 15 Apr 2024
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Closing Below Previous Low for 2 Days Closing Below Previous Low for 2 Days

Alkem Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,773.51 1,535.00 -0.3%
Cipla Ltd. 111,517.58 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. 100,257.78 6,041.25 +0.5%
Divi's Laboratories Ltd. 98,636.18 3,758.40 +1.1%
Zydus Lifesciences Ltd. 94,082.88 949.90 +1.6%
Mankind Pharma Ltd. 90,721.26 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. 90,631.78 6,296.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.52 1,535.00 -0.3%
Cipla Ltd. Consolidated 2023-12 30.07 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.18 6,041.25 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 71.32 3,758.40 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.64 949.90 +1.6%
Mankind Pharma Ltd. Consolidated 2023-12 52.53 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 114.82 6,296.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.93 1,535.00 -0.3%
Cipla Ltd. Consolidated 2023-12 4.31 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 6,041.25 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,758.40 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.99 949.90 +1.6%
Mankind Pharma Ltd. Consolidated 2023-12 10.21 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.42 6,296.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,535.00 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,041.25 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,758.40 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 949.90 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,296.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,535.00 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,041.25 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,758.40 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 949.90 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,296.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,535.00 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,041.25 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,758.40 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 949.90 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,296.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,535.00 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,041.25 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,758.40 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 949.90 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,296.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,535.00 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,041.25 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,758.40 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 949.90 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,288.60 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,296.00 -0.1%

Alkem Laboratories Ltd. FAQ's

What is Alkem Laboratories share price?

Can I buy Alkem Laboratories shares now?

What is the Dividend Yield of Alkem Laboratories?

What is the Market Cap of Alkem Laboratories?

What are the key metrics to analyse Alkem Laboratories?

What is the 52 Week High and Low of Alkem Laboratories?

What is the trend of Alkem Laboratories share price?